Ustekinumab
anti-inflammatory biologic · immunomodulator
Nothing to addBy the Layer Nutrition editorial team · How the atlas classifies the 664 molecules
What this medicine is for
Ustekinumab is a medicine in the “anti-inflammatory biotherapy (immunomodulator)” category. This medicine modulates or restrains the immune system, in an autoimmune disease or after a transplant; it requires close monitoring.
For Ustekinumab, in practice: Treats an inflammatory or autoimmune disease. It is generally taken over the long term, within regular monitoring, and is not stopped on your own initiative.
Under which brands it is found
Ustekinumab is found in around 9 presentations listed in France. It can be found under several brand names and as generics.
- Imuldosa
- Otulfi
- Pyzchiva
- Stelara
- Steqeyma
- Usrenty
- Uzpruvo
- Wezenla
- and other presentations
Generics and the original brand are equivalent for the active substance; only the appearance, the name or the excipients may differ.
Do you need a supplement? No.
Nothing to add here. Ustekinumab does not fall under any of our references, and no single-ingredient supplement makes credible sense as a complement. Rather than placing a product on principle, we leave this page without a purchase recommendation. If you are otherwise taking a statin, an antidiabetic, a PPI, a contraceptive or a beta-blocker, that is where we can be useful.
Related molecules
To explore in the « Pain and inflammation » family and its neighbours.
See the whole « Pain and inflammation » family · Back to the atlas